微生物导向口服抗生素降低二期翻修后感染失败率:多中心随机对照试验
本研究为多中心随机对照试验,纳入185例因慢性髋或膝假体周围感染行二期翻修的患者,随机分为再植入后接受三个月微生物导向口服抗生素组与无抗生素组。结果显示抗生素组因再次感染失败率为12.5%,显著低于无抗生素组的28.6%(p=0.012)。
要点
- 二期翻修再植入后三个月微生物导向口服抗生素可显著降低因再感染导致的失败率。
- 抗生素组因再次感染失败率为12.5%,无抗生素组为28.6%,差异有统计学意义(p=0.012)。
- 治疗组中6.9%的患者因抗生素相关不良反应严重而需停药。
核心结论
- 三个月微生物导向口服抗生素可显著降低慢性假体周围感染二期翻修后因再次感染导致的失败率。
研究设计与样本
- 多中心随机对照试验,共185例因慢性髋或膝假体周围感染行二期翻修的患者前瞻性入组,来自七个中心。
- 93例随机接受再植入后三个月微生物导向口服抗生素,88例随机不接受抗生素,4例在随机化前退出。
- 181例随机化患者中,28例失访,6例在两年随访前死亡,5例培养阴性感染被排除,最终142例随访,平均3.3年(范围2.0至7.6年)。
主要发现
- 抗生素组72例中9例(12.5%)因再次感染失败,无抗生素组70例中20例(28.6%)因再次感染失败(p=0.012)。
- 治疗组5例(6.9%)出现与所用抗生素相关的不良反应,严重程度足以需要停药。
关键数值与推荐
- 主要终点为因再次感染导致的失败;抗生素组失败率12.5%(9/72),无抗生素组失败率28.6%(20/70),p=0.012。
- 治疗组抗生素相关不良反应导致停药的比例为6.9%(5例)。
临床怎么用
- 对于慢性髋或膝假体周围感染行二期翻修的患者,再植入后可考虑给予三个月微生物导向口服抗生素以降低再感染失败风险。
- 使用过程中需监测抗生素相关不良反应,严重者需停药。
局限性
- 28例失访、6例两年随访前死亡、5例培养阴性感染被排除,最终仅142例纳入分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to determine if a three-month course of microorganism-directed oral antibiotics reduces the rate of failure due to further infection following two-stage revision for chronic prosthetic joint infection (PJI) of the hip and knee. METHODS: A total of 185 patients undergoing a two-stage revision in seven different centres were prospectively enrolled. Of these patients, 93 were randomized to receive microorganism-directed oral antibiotics for three months following reimplantation; 88 were randomized to receive no antibiotics, and four were withdrawn before randomization. Of the 181 randomized patients, 28 were lost to follow-up, six died before two years follow-up, and five with culture negative infections were excluded. The remaining 142 patients were followed for a mean of 3.3 years (2.0 to 7.6) with failure due to a further infection as the primary endpoint. Patients who were treated with antibiotics were also assessed for their adherence to the medication regime and for side effects to antibiotics. RESULTS: Nine of 72 patients (12.5%) who received antibiotics failed due to further infection compared with 20 of 70 patients (28.6%) who did not receive antibiotics (p = 0.012). Five patients (6.9%) in the treatment group experienced adverse effects related to the administered antibiotics severe enough to warrant discontinuation. CONCLUSION: This multicentre randomized controlled trial showed that a three-month course of microorganism-directed, oral antibiotics significantly reduced the rate of failure due to further infection following a two-stage revision of total hip or knee arthroplasty for chronic PJI. Cite this article: Bone Joint J 2020;102-B(6 Supple A):3-9.
引用
- Yang J, Parvizi J, Hansen EN, et al. 2020 Mark Coventry Award: Microorganism-directed oral antibiotics reduce the rate of failure due to further infection after two-stage revision hip or knee arthroplasty for chronic infection: a multicentre randomized controlled trial at a minimum of two years. Bone Joint J. 2020. PMID: 32475278. doi:10.1302/0301-620X.102B6.BJJ-2019-1596.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。